Company Filing History:
4 out of 15,488 
3 out of 790 
1 out of 31 
Years Active: 2001-2016
Title: Innovations in Parkinson's Disease Treatment by Janet Cunningham
Introduction
Janet Cunningham is a prominent inventor based in Alameda, CA (US), known for her significant contributions to the field of neuroscience. She has been instrumental in developing methods for treating Parkinson's disease, focusing on innovative approaches using viral vectors. With a total of 5 patents to her name, her work has the potential to transform therapeutic strategies for central nervous system disorders.
Latest Patents
Cunningham's latest patents include groundbreaking methods of treating Parkinson's disease using viral vectors. One of her notable inventions involves the delivery of recombinant adeno-associated virus (rAAV) virions to the central nervous system (CNS) through convection enhanced delivery (CED). This method incorporates a nucleic acid sequence encoding a therapeutic polypeptide, which can be utilized for treating CNS disorders, particularly Parkinson's disease. Another patent focuses on delivering rAAV virions that contain a transgene encoding aromatic amino acid decarboxylase (AADC), which is administered to the brain of a mammal using a non-manual pump. These innovative methods aim to address disorders involving the neurotransmitter dopamine.
Career Highlights
Throughout her career, Janet Cunningham has worked with esteemed organizations such as the University of California and Genzyme Corporation. Her research has significantly advanced the understanding and treatment of neurological disorders, particularly those affecting motor function and cognition.
Collaborations
Cunningham has collaborated with notable professionals in her field, including Krys Bankiewicz and Jamie L. Eberling. These partnerships have fostered a collaborative environment that enhances the development of effective treatment methodologies.
Conclusion
Janet Cunningham's innovative work in the treatment of Parkinson's disease showcases her dedication to advancing medical science. Her patents reflect a commitment to improving the lives of individuals affected by CNS disorders. Through her research and collaborations, she continues to pave the way for future breakthroughs in neuroscience.